Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardian Pharmacy Services (GRDN) EBIT (2023 - 2025)

Historic EBIT for Guardian Pharmacy Services (GRDN) over the last 3 years, with Q3 2025 value amounting to $16.4 million.

  • Guardian Pharmacy Services' EBIT rose 11563.29% to $16.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.7 million, marking a year-over-year increase of 19149.35%. This contributed to the annual value of -$62.9 million for FY2024, which is 25366.58% down from last year.
  • Per Guardian Pharmacy Services' latest filing, its EBIT stood at $16.4 million for Q3 2025, which was up 11563.29% from $12.6 million recorded in Q2 2025.
  • Guardian Pharmacy Services' 5-year EBIT high stood at $17.0 million for Q2 2024, and its period low was -$104.6 million during Q3 2024.
  • For the 3-year period, Guardian Pharmacy Services' EBIT averaged around -$1.3 million, with its median value being $13.0 million (2025).
  • As far as peak fluctuations go, Guardian Pharmacy Services' EBIT plummeted by 155265.4% in 2024, and later soared by 11563.29% in 2025.
  • Over the past 3 years, Guardian Pharmacy Services' EBIT (Quarter) stood at $15.5 million in 2023, then rose by 7.93% to $16.8 million in 2024, then decreased by 2.39% to $16.4 million in 2025.
  • Its EBIT stands at $16.4 million for Q3 2025, versus $12.6 million for Q2 2025 and $13.0 million for Q1 2025.